Fertility clinics provide assisted reproductive technology (ART) services including IVF, IUI, egg freezing, genetic testing, and donor programs to individuals and couples experiencing infertility. The industry sits at the intersection of elective healthcare and medically necessary treatment, commanding premium self-pay pricing while increasingly benefiting from expanded insurance mandates. Private equity consolidation has accelerated significantly since 2015, creating well-capitalized national platforms competing against independent physician-owned clinics.
Who buys these: Private equity firms specializing in healthcare, large regional fertility networks, strategic acquirers such as US Fertility or CCRM, and high-net-worth physicians seeking platform investments
5–9×
Typical EBITDA multiple
$2M–$5M
Revenue range
Growing
Market trend
Minimum $1.5M EBITDA, established IVF laboratory with SART membership, at least one board-certified reproductive endocrinologist under contract, strong patient review scores, diversified payer mix with some self-pay, and clean regulatory history with no CDC adverse reports
Get Deal Flow In Your Inbox
New Fertility Clinic acquisition targets delivered weekly — free to join.
Key items to investigate when evaluating a Fertility Clinic acquisition
Seller Intelligence
Who sells Fertility Clinic businesses?
Founder reproductive endocrinologists approaching retirement age (55–70), physician partners seeking liquidity events, and small group practices unable to compete with larger fertility networks without capital investment
Typical exit timeline: 18–24 months
Fertility Clinic businesses in the $2M–$5M revenue range typically sell for 5–9× EBITDA. Minimum $1.5M EBITDA, established IVF laboratory with SART membership, at least one board-certified reproductive endocrinologist under contract, strong patient review scores, diversified payer mix with some self-pay, and clean regulatory history with no CDC adverse reports
Fertility Clinic businesses typically trade at 5–9× EBITDA in the lower middle market. The market is moderately fragmented with growing demand, which supports premium multiples.
SBA eligibility for Fertility Clinic businesses depends on the specific deal. The most common structures are: Asset purchase with physician employment agreement rolled into a Professional Services Agreement through a Management Services Organization (MSO) structure; Equity recapitalization where founding physician retains 20–40% equity stake and receives earnout tied to patient volume and EBITDA growth over 3–5 years.
Key due diligence areas include: Physician employment agreements, non-competes, and transition risk if key RE departs post-close; CDC ART success rate reports, SART data, and laboratory accreditation status under CLIA; Payer mix analysis including self-pay rates, insurance reimbursement contracts, and fertility benefit employer agreements; IVF laboratory equipment condition, age, maintenance records, and estimated capital replacement costs; Patient data privacy compliance under HIPAA, state genetic information laws, and embryo disposition consent protocols.
Related Searches
DealFlow OS surfaces acquisition targets, scores seller motivation, and generates outreach — all in one place.
Start finding deals — freeNo credit card required
For Buyers
For Sellers